This out of favor AI stock is 'getting much more interesting': Mizuho By Investing.com - May 24, 2024 ADBE -0.25%
UoM consumers current conditions Index final May 69.6 vs prelim May 68.8; final April 79.0 By Investing.com - May 24, 2024 SPY +0.91%
UoM consumers sentiment final May 69.1 vs Prelim 67.4, April 77.2 By Investing.com - May 24, 2024 SPY +0.91%
JPMorgan asks: Is it time for Long Energy vs. Short Tech stocks again? By Investing.com - May 24, 2024
Survey suggests 'largely stable demand environment' in IT hardware sector By Investing.com - May 24, 2024 NTAP +3.37%
Nvidia is now a significant Ethernet player: Rosenblatt By Investing.com - May 24, 2024 NVDA -0.82%ANET -1.96%
Martin Midstream Partners Announces $3.05/unit Buyout Offer from Martin Resource Management Corporation By Investing.com - May 24, 2024 MMLP -4.60%
Apple (AAPL) iPhone showing stabilization 'with big AI moment ahead' - Wedbush By Investing.com - May 24, 2024 AAPL +0.54%
Capital One Financial and Walmart End Consumer Card Partnership Agreement By Investing.com - May 24, 2024 WMT +1.34%COF +1.06%
Netlist awarded $445m in patent infringement trial against Micron By Investing.com - May 24, 2024 MU -1.01%NLST +2.82%
Santander Appoints Head of New Sovereign Wealth Fund Business - Reuters By Investing.com - May 24, 2024 SAN +2.14%
Google Invested $350M in India's Flipkart in Latest Funding Round - Reuters By Investing.com - May 24, 2024 GOOGL +0.23%
Samsung HBM failing Nvidia tests is another positive for Micron - Wells Fargo By Investing.com - May 24, 2024 1 NVDA -0.82%
Kazakh Oil Flow to Germany Intact With Druzhba Issue Resolved - Reuters By Investing.com - May 24, 2024 USO -0.94%
Cathie Wood's ARK Venture Fund backs Firmly for streamlined online shopping By Investing.com - May 24, 2024
Exact Sciences Co receives Investment Bank Analyst Rating Update By Investing.com - May 24, 2024 EXAS +0.44%
Exact Sciences Weakness Tied to FDA Panel Support for Approval of Rival Test By Investing.com - May 24, 2024 EXAS +0.44%GH -1.35%
Guardant Health : FDA Advisory Committee Panel Strongly Recommends Approval of Shield Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening Option By Investing.com - May 24, 2024 GH -1.35%